Sigma Labs Stock Forecast, Price & News

Sigma Labs (NASDAQ:SGLB) Frequently Asked Questions

Is Sigma Labs a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sigma Labs in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Sigma Labs stock.
View analyst ratings for Sigma Labs or view top-rated stocks.

How has Sigma Labs' stock price been impacted by COVID-19 (Coronavirus)?

Sigma Labs' stock was trading at $4.76 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SGLB stock has decreased by 60.9% and is now trading at $1.86.
View which stocks have been most impacted by COVID-19.

Are investors shorting Sigma Labs?

Sigma Labs saw a drop in short interest during the month of December. As of December 15th, there was short interest totaling 303,600 shares, a drop of 36.4% from the November 30th total of 477,100 shares. Based on an average daily trading volume, of 130,600 shares, the short-interest ratio is presently 2.3 days. Currently, 3.0% of the shares of the stock are sold short.
View Sigma Labs' Short Interest.

When is Sigma Labs' next earnings date?

Sigma Labs is scheduled to release its next quarterly earnings announcement on Wednesday, March 23rd 2022.
View our earnings forecast for Sigma Labs.

How were Sigma Labs' earnings last quarter?

Sigma Labs, Inc. (NASDAQ:SGLB) released its quarterly earnings results on Thursday, October, 21st. The company reported ($0.24) EPS for the quarter, missing the Zacks' consensus estimate of ($0.12) by $0.12. The company had revenue of $0.70 million for the quarter, compared to the consensus estimate of $0.63 million. Sigma Labs had a negative trailing twelve-month return on equity of 51.93% and a negative net margin of 440.01%. During the same period last year, the firm earned ($0.42) earnings per share.
View Sigma Labs' earnings history.

What price target have analysts set for SGLB?

1 equities research analysts have issued twelve-month target prices for Sigma Labs' shares. Their forecasts range from $6.00 to $6.00. On average, they expect Sigma Labs' stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 222.6% from the stock's current price.
View analysts' price targets for Sigma Labs or view top-rated stocks among Wall Street analysts.

Who are Sigma Labs' key executives?

Sigma Labs' management team includes the following people:

• Mark K. Ruport, President, Chief Executive Officer & Director (LinkedIn Profile)
• Frank Donald Orzechowski, Chief Financial Officer, Secretary & Treasurer
• Darren P. Beckett, Chief Technology Officer
• Jacob Brunsberg, Senior Vice President
• Ronald Fisher, Vice President-Business Development

Who are some of Sigma Labs' key competitors?

Some companies that are related to Sigma Labs include Dogness (International) (DOGZ), VirTra (VTSI), Conversion Labs (CVLBD), Summer Infant (SUMR), Trans-Lux (TNLX), HempAmericana (HMPQ), Jason Industries (JASN), Dais (DLYT), Jason Industries (JASNQ), China Gengsheng Minerals (CHGS), Ingen Technologies (IGNT) and Kid Brands (KIDBQ).
View all of SGLB's competitors.

What other stocks do shareholders of Sigma Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sigma Labs investors own include Micron Technology (MU), Sorrento Therapeutics (SRNE), Ampio Pharmaceuticals (AMPE), Capricor Therapeutics (CAPR), Diffusion Pharmaceuticals (DFFN), OPKO Health (OPK), Trevena (TRVN), Allena Pharmaceuticals (ALNA), Advanced Micro Devices (AMD) and Bellerophon Therapeutics (BLPH).

What is Sigma Labs' stock symbol?

Sigma Labs trades on the NASDAQ under the ticker symbol "SGLB."

Who are Sigma Labs' major shareholders?

Sigma Labs' stock is owned by many different institutional and retail investors. Top institutional shareholders include Cutler Group LP (0.00%).
View institutional ownership trends for Sigma Labs.

Which major investors are selling Sigma Labs stock?

SGLB stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.
View insider buying and selling activity for Sigma Labs or view top insider-selling stocks.

How do I buy shares of Sigma Labs?

Shares of SGLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sigma Labs' stock price today?

One share of SGLB stock can currently be purchased for approximately $1.86.

How much money does Sigma Labs make?

Sigma Labs has a market capitalization of $19.52 million and generates $810 thousand in revenue each year. The company earns $-5.20 million in net income (profit) each year or ($0.60) on an earnings per share basis.

How many employees does Sigma Labs have?

Sigma Labs employs 20 workers across the globe.

What is Sigma Labs' official website?

The official website for Sigma Labs is www.sigmalabsinc.com.

Where are Sigma Labs' headquarters?

Sigma Labs is headquartered at 3900 PASEO DEL SOL, SANTA FE NM, 87507.

How can I contact Sigma Labs?

Sigma Labs' mailing address is 3900 PASEO DEL SOL, SANTA FE NM, 87507. The company can be reached via phone at (505) 438-2576, via email at [email protected], or via fax at 505-424-3174.